News

Hillhurst Biopharmaceuticals Secures Funding for Parkinson's Study

Hillhurst Biopharmaceuticals Secures Funding for Parkinson's Study

Hillhurst Biopharmaceuticals Secures Significant Grants

Today, Hillhurst Biopharmaceuticals, Inc. (NASDAQ: HILL), a trailblazer in crafting innovative liquid drug therapies, has brought in an impressive $6.3 million in grants to propel its Phase 2a clinical trial focused on Parkinson's disease. The support includes $2 million sourced from The Michael J. Fox Foundation and $4.3 million from the Farmer Family Foundation, in collaboration with a respected medical institution.

Overview of the Clinical Study

This pivotal study aims to investigate a treatment regimen lasting 14 days, involving 36 individuals diagnosed with Parkinson's disease. Central to this research is the assessment of safety and pharmacokinetics, along with the identification of actionable biomarkers. Set to commence in early 2025, this study seeks to unveil how Hillhurst Bio's groundbreaking approach may shield patients against the debilitating effects of disease progression, targeting essential pathways crucial for cellular protection.

Hillhurst Bio's Commitment to Innovation

Hillhurst Bio's dedication to addressing unmet medical necessities drives its mission. This latest study exemplifies progress toward future therapies for neurodegenerative disorders. With assistance from organizations such as The Michael J. Fox Foundation and the Farmer Family Foundation, which champion patient advocacy and support innovative research, Hillhurst is positioned to make meaningful advancements in treatment options.

Appreciation for Collaborators and Supporters

Expressing heartfelt gratitude towards its collaborators and supporters, Hillhurst Bio remains committed to pioneering transformative treatments for those in need around the world. The company views this funding as a crucial investment in the health and well-being of patients navigating chronic conditions.

About the Farmer Family Foundation

The Farmer Family Foundation, based in Cincinnati, is dedicated to innovative programs that can significantly impact individuals' lives. Founded in 1988, its focus extends primarily to enhancing K-12 education for at-risk communities and fostering economic self-sufficiency. The Foundation also actively supports healthcare research beyond its immediate region.

About Hillhurst Biopharmaceuticals, Inc.

Hillhurst Biopharmaceuticals is dedicated to advancing its proprietary GLASS™ platform, aimed at developing revolutionary drug products utilizing therapeutic gases. This platform has unlocked potential for novel liquid investigational therapies, especially targeting diseases such as Parkinson's disease, sickle cell disease, and acute pain challenges.

Frequently Asked Questions

What is the purpose of the $6.3 million grant?

This grant will fund Hillhurst Bio's Phase 2a clinical study aimed at treating Parkinson's disease through innovative therapeutic approaches.

Which organizations are providing the funding?

Funding is provided by The Michael J. Fox Foundation and the Farmer Family Foundation.

When will the clinical study begin?

The clinical study is scheduled to start in early 2025.

What are the main goals of the study?

The study aims to assess the safety, pharmacokinetics, and biomarkers after a 14-day treatment regimen in participants.

What conditions is Hillhurst targeting with its research?

Hillhurst is focusing on Parkinson's disease, among other conditions like sickle cell disease and acute pain.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 5

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 6

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
Microplastics Webinar: Navigating Complex Regulations

Updated Category News Views 7

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

Continue Reading
New Podcast by Paralyzed Veterans of America Offers Unique Insights

Updated Category News Views 6

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Continue Reading
CATL Opens Europe's Largest Battery Service Hub

Updated Category News Views 6

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 6

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading
NORD Honors Innovators Shaping Rare Disease Treatment

Updated Category News Views 9

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 5

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 5

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading
illycaffè's B Corp™ Recertification Reflects Bold Commitment

Updated Category News Views 6

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Continue Reading

Top 5 Most Recently Viewed Articles

Hamilton Beach Brands Announces Quarterly Dividend for Shareholders

Updated Category News Views 93

Hamilton Beach Brands Holding Company Declares Dividend Hamilton Beach Brands Holding Company (NYSE: HBB), a notable player in the small appliance market, recently made an announcement regarding its financial strategy. The Board of Directors declared a regular cash dividend of $0.115 per share. This reflects the company’s ongoing commitment to its shareholders and...

Continue Reading
Southern Champion Tray Elevates Packaging Production with New Press

Updated Category News Views 196

Southern Champion Tray Enhances Packaging Capabilities Southern Champion Tray is excited to reveal the addition of a remarkable new Heidelberg Boardmaster Flexographic Press at its production facility. This cutting-edge investment reaffirms SCT's dedication to sustainability and exceptional customer service in the packaging industry. Investment in Advanced Technology The...

Continue Reading
Trillium Surveyor and Kaiko Forge Partnership for Trade Surveillance

Updated Category News Views 85

Trillium Surveyor and Kaiko Forge Partnership for Trade Surveillance In an exciting development for the financial services industry, Trillium Surveyor, a recognized provider of trade surveillance and execution solutions, has announced a strategic partnership with Kaiko, a prominent name in cryptocurrency market data. This collaboration aims to deliver advanced solutions...

Continue Reading
Alliance Trust's Latest Net Asset Value Overview

Updated Category News Views 98

Alliance Trust got its latest Net Asset Value (NAV) report out, and let me tell ya—traders were buzzing about what it all means for the firm’s financial standing. As always, knowing the numbers is crucial if you're eyeing this stock. NAV Breakdown: A Deep Dive into Alliance Trust's Figures The current NAV per ordinary share tells a story worth dissecting: Excluding...

Continue Reading
Kaldalón hf. Enhances Real Estate Holdings with Strategic Acquisition

Updated Category News Views 88

Kaldalón hf. Expands Property Portfolio Through Acquisition Kaldalón hf. has made a significant move by acquiring the complete property portfolio of FÍ fasteignafélag. This acquisition includes a diverse range of real estate assets that will bolster Kaldalón's position in the market. Understanding the Property Portfolio The portfolio encompasses 11 properties...

Continue Reading